Biocom California (@biocomca) 's Twitter Profile
Biocom California

@biocomca

We are California’s leading advocate for life sciences.

ID: 55586971

linkhttp://www.biocom.org calendar_today10-07-2009 15:17:44

8,8K Tweet

7,7K Takipçi

2,2K Takip Edilen

Biocom California (@biocomca) 's Twitter Profile Photo

Congratulations to our member Nuravax on securing a $3M NIH grant for a Phase 1 trial this year for Duvax, the first Alzheimer's vaccine targeting both beta-amyloid and tau. Learn more about this game-changer in early intervention: yhoo.it/3GPvVkS

Congratulations to our member Nuravax on securing a $3M NIH grant for a Phase 1 trial this year for Duvax, the first Alzheimer's vaccine targeting both beta-amyloid and tau. Learn more about this game-changer in early intervention: yhoo.it/3GPvVkS
Biocom California (@biocomca) 's Twitter Profile Photo

Biocom California and KoreaBIO have signed an MOU to foster collaboration between life science companies in California and South Korea. This partnership aims to drive innovation, funding and new market opportunities across both regions. Learn more: bit.ly/3S2y7b5

Biocom California and KoreaBIO have signed an MOU to foster collaboration between life science companies in California and South Korea. This partnership aims to drive innovation, funding and new market opportunities across both regions. Learn more: bit.ly/3S2y7b5
Biocom California (@biocomca) 's Twitter Profile Photo

Honored to share that our president & CEO, Tim Scott, has been awarded UC San Diego's Illustrious Alumni Award for his impact on life sciences. Congratulations, Tim—your leadership continues to advance innovation across the state and inspire our community. youtube.com/watch?v=qf-Alc…

Biocom California (@biocomca) 's Twitter Profile Photo

Welcoming 500+ aspiring life science professionals to today's Bay Area Life Science Career Expo with Biocom California Institute! 15+ hiring companies are exploring open positions, while industry panels and workshops will bring insights to the next generation of talent.

Welcoming 500+ aspiring life science professionals to today's Bay Area Life Science Career Expo with <a href="/BiocomInstitute/">Biocom California Institute</a>! 15+ hiring companies are exploring open positions, while industry panels and workshops will bring insights to the next generation of talent.
Biocom California (@biocomca) 's Twitter Profile Photo

Biocom California maintains its opposition to the Most Favored Nation (MFN) price setting policy, which threatens innovation, disrupts access to life-saving treatments and undermines the next generation of life science research. Read our statement: bit.ly/3YNLlMB

Biocom California maintains its opposition to the Most Favored Nation (MFN) price setting policy, which threatens innovation, disrupts access to life-saving treatments and undermines the next generation of life science research. Read our statement: bit.ly/3YNLlMB
Biocom California (@biocomca) 's Twitter Profile Photo

Each year we’ve greeted cyclists at Bike Anywhere Day, our pit stop gets bigger. This year included members Vertex Pharmaceuticals Eli Lilly and Company Thermo Fisher at the Campus Point Mega Stop. There’s still time to come by for free coffee, snacks and giveaways.

Each year we’ve greeted cyclists at Bike Anywhere Day, our pit stop gets bigger. This year included members <a href="/VertexPharma/">Vertex Pharmaceuticals</a> <a href="/EliLillyandCo/">Eli Lilly and Company</a> <a href="/thermofisher/">Thermo Fisher</a> at the Campus Point Mega Stop.

There’s still time to come by for free coffee, snacks and giveaways.
Biocom California (@biocomca) 's Twitter Profile Photo

In this week's San Diego Newsletter: Adcentrx granted Fast Track for ADRX-0706 in advanced cervical cancer; Iambic Therapeutics launches Enchant v2, its next-gen AI model for drug discovery; Thermo Fisher is investing $2B to expand U.S. mfg. and R&D. Subscribe: bit.ly/4iqn5b1

In this week's San Diego Newsletter: Adcentrx granted Fast Track for ADRX-0706 in advanced cervical cancer; <a href="/iambic_ai/">Iambic Therapeutics</a> launches Enchant v2, its next-gen AI model for drug discovery; <a href="/thermofisher/">Thermo Fisher</a> is investing $2B to expand U.S. mfg. and R&amp;D. Subscribe: bit.ly/4iqn5b1
Biocom California (@biocomca) 's Twitter Profile Photo

Great evening yesterday celebrating the hard work of the staff of our local elected officials–the public servants who provide information, guidance and resources when #LifeScience issues arise. Thank you SDG&E and Longfellow Real Estate Partners for helping make this event possible.

Great evening yesterday celebrating the hard work of the staff of our local elected officials–the public servants who provide information, guidance and resources when #LifeScience issues arise. Thank you <a href="/SDGE/">SDG&E</a> and <a href="/LongfellowREP/">Longfellow Real Estate Partners</a> for helping make this event possible.
Biocom California (@biocomca) 's Twitter Profile Photo

In this week's Greater LA Newsletter: City of Hope to open cancer specialty hospital in OC this year; Nuravax secures $3M NIH grant for Phase 1 trial of Alzheimer’s vaccine, Duvax; Xencor reports positive interim results for XmAb942 in IBD study. Subscribe: bit.ly/3WFbOLh

In this week's Greater LA Newsletter: <a href="/cityofhope/">City of Hope</a> to open cancer specialty hospital in OC this year; Nuravax secures $3M NIH grant for Phase 1 trial of Alzheimer’s vaccine, Duvax; Xencor reports positive interim results for XmAb942 in IBD study. Subscribe: bit.ly/3WFbOLh
Biocom California (@biocomca) 's Twitter Profile Photo

Exciting news in global life science collaboration: Biocom California and KoreaBIO signed an MOU to strengthen life science ties between California and South Korea, boosting co-investment, innovation and international market expansion. Learn more: bit.ly/3S2y7b5

Exciting news in global life science collaboration: Biocom California and KoreaBIO signed an MOU to strengthen life science ties between California and South Korea, boosting co-investment, innovation and international market expansion. Learn more: bit.ly/3S2y7b5
Biocom California (@biocomca) 's Twitter Profile Photo

Join us at the Life Science Workforce Symposium with Biocom California Institute on August 26 to connect with emerging talent from diverse backgrounds, share your career story and inspire the next generation of life science leaders. Learn more: bit.ly/3GMKdTv

Join us at the Life Science Workforce Symposium with <a href="/BiocomInstitute/">Biocom California Institute</a> on August 26 to connect with emerging talent from diverse backgrounds, share your career story and inspire the next generation of life science leaders. Learn more: bit.ly/3GMKdTv
Biocom California (@biocomca) 's Twitter Profile Photo

In this week's Bay Area Newsletter: 4DMT receives FDA RMAT for 4D-150; Ansa Biotechnologies redefines synthetic DNA; Brightseed and Haleon partner on AI for small molecule discovery; Intuitive gains FDA clearance for da Vinci single port. Subscribe: bit.ly/3PVYyhu

In this week's Bay Area Newsletter: 4DMT receives FDA RMAT for 4D-150; <a href="/AnsaBio/">Ansa Biotechnologies</a> redefines synthetic DNA; <a href="/BrightseedBio/">Brightseed</a> and Haleon partner on AI for small molecule discovery; <a href="/IntuitiveSurg/">Intuitive</a> gains FDA clearance for da Vinci single port. Subscribe: bit.ly/3PVYyhu
Biocom California (@biocomca) 's Twitter Profile Photo

Thank you to the CA State Senate for passing Senator John Laird’s SJR-4 urging Congress to reverse harmful NIH funding cuts. CA currently gets $5B+ annually, with $2B+ going to UCs & CSUs. These cuts threaten future treatments, current research & jobs. #CALeg #CaliforniaLegislature

Biocom California (@biocomca) 's Twitter Profile Photo

Deepen your expertise in drug development with the new Pharmacology and the ADMET Process course offered by our member UC San Diego Division of Extended Studies. Dive into drug action, pharmacokinetics, pharmacodynamics and toxicology through real-world case studies. Learn more: bit.ly/3YQ2TYx

Deepen your expertise in drug development with the new Pharmacology and the ADMET Process course offered by our member <a href="/UCSDExtStudies/">UC San Diego Division of Extended Studies</a>. Dive into drug action, pharmacokinetics, pharmacodynamics and toxicology through real-world case studies.  Learn more: bit.ly/3YQ2TYx
Biocom California (@biocomca) 's Twitter Profile Photo

Discover the transformative ideas redefining healthcare in the New Era of Life Sciences Report by Newsweek, featuring an interview with our former president & CEO on key factors driving California's leadership in the life sciences. Read the interview: bit.ly/4j8gmSI

Discover the transformative ideas redefining healthcare in the New Era of Life Sciences Report by <a href="/Newsweek/">Newsweek</a>, featuring an interview with our former president &amp; CEO on key factors driving California's leadership in the life sciences. Read the interview: bit.ly/4j8gmSI
Biocom California (@biocomca) 's Twitter Profile Photo

Biocom California was proud to join #BIOKOREA2025 in Seoul to strengthen the growing partnerships between California and Korea’s biotech ecosystems. Special thanks to our delegation, including president emeritus Joe Panetta, for representing our community on the global stage.

Biocom California was proud to join #BIOKOREA2025 in Seoul to strengthen the growing partnerships between California and Korea’s biotech ecosystems. Special thanks to our delegation, including president emeritus Joe Panetta, for representing our community on the global stage.